RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
Clinical trial NCT06397313 · RECRUITING
Trial details
- NCT number
- NCT06397313
- Sponsor
- Ryvu Therapeutics SA
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-19
- Primary completion
- 2026-06-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.